Dr. Vemula obtained masters (M.Sc., Org. Chem.) degree from Osmania University, Hyderabad and Ph.D. from Indian Institute of Science, Bangalore in Organic Chemistry (2005). Subsequently he carried out over two years postdoctoral research at the City College of New York and over four years at Harvard-MIT Division of Health Sciences and Technology in Harvard Medical School in affiliation with Brigham and Women's Hospital. In 2009, he was selected as one of the thirteen fellows in the USA for the prestigious postdoctoral entrepreneur fellowship from the Ewing Marion Kauffman Foundation, where he received exposure to entrepreneurial education and closely worked with the foundation to commercialize the biomedical technologies.
Dr. Vemula's research interests are in the fields of biomaterials, drug delivery, gene delivery and translation science. He is an Assistant Investigator at the Institute for Stem Cell Biology and Regenerative Medicine (inStem), Bangalore. Several technologies developed by he and team have formed the foundation for multiple products on the market and currently under development and for the launch of two companies including Skintifique and Alivio Therapeutics.
His laboratory has been funded by multiple foundations, companies, and governmental funding agencies including Manus Biosciences, the Lady Tata Memorial Trust, the Department of Biotechnology, Department of Science and Technology, BIRAC (Biotechnology Industry Research Assistant Council), Science and Engineering Research Board (SERB).
Vemula’s work has been discussed in hundreds of newspapers, online websites, television newscasts, and radio shows around the world including The New York Times, CNN, ABC News, NBC, Boston Globe, LA Times, BBC, Discovery, National Geographic, The Hindu, The Times of India, Deccan Herald and many more.
Vemula is an associate editor of Bulletin of Materials Science, a journal of Springer and Indian Academy of Sciences.
At present, Vemula’s lab is focusing to develop biomaterials and bioengineering concepts to solve huge unmet clinical needs including protection of transplanted organs, developing therapeutics for inflammatory/infectious diseases and prevention of pesticide-induced lethality.
G-fab technology: Antiviral mask/fabric - a conversation with QtSTEAM team
TEDx at KIITUniversity March 2019
TEDx at Siddaganga Institute of Technology 2019
An interview about STEAM education with Santosh Avvannavar, QtPi Robotics 2019
praveenv AT instem.res.in
Praveen Kumar Vemula
Institute for Stem Cell Biology and Regenerative Medicine (inStem)
UAS-GKVK Campus, Bellary Road
Awards, Fellowships and Academic Service (selective)
2017 - present, An Associate Editor, Bulletin of Materials Science (Springer and Indian Academy of Sciences)
2015 - 2017, An Associate Editor, RSC Advances (Royal Society of Chemistry)
2012 Ramalingaswami ReEntry Fellowship 2011-12 by Department of Biotechnology, Govt. of India
2011 Excellence in Research Award, Fall 2011 awards, Brigham and Women's Hospital, Harvard Med. Sch.
2010 MIT $100K Business Plan Competition finalist, and runner-up, May 2010
Track Winner ($20,000, Product and Services) at MIT $100K Business Plan Competition, 2010.
2009 Kauffman Foundation Entrepreneur Postdoctoral Fellow
(One of the thirteen recipients in USA for cross-disciplinary fellowship)
2006 Best cover page of the year-2006, Royal Society of Chemistry Journal Soft Matter
Apart from science, badminton is my passion. I just love that game!
(Disclaimer: The quality of the game is not necessarily proportional to the level of passion!!!)